DNA FOUND IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PARTICLES MAY NOT BE REQUIRED FOR INFECTIVITY

被引:32
|
作者
ARTS, EJ
MAK, J
KLEIMAN, L
WAINBERG, MA
机构
[1] MCGILL UNIV,JEWISH GEN HOSP,LADY DAVIS INST MED RES,MONTREAL H3T 1E2,PQ,CANADA
[2] MCGILL UNIV,DEPT MICROBIOL & IMMUNOL,MONTREAL H3A 2B4,PQ,CANADA
来源
关键词
D O I
10.1099/0022-1317-75-7-1605
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
We have studied the presence and significance of retroviral genome-derived DNA in the core of human immunodeficiency virus (HIV) particles produced from transfections of HXB2 expression vectors in COS-7 cells and from HIV type 1 IIIB chronically infected H9 cells. Viruses purified by sucrose cushion centrifugation and treated with DNase I contained 1000-fold more viral RNA than DNA. However protease-defective viruses that contained only p160(gag-pol) had less than 100 times the amount of DNA in their cores than wild-type viruses suggesting that the p66/p51 form of reverse transcriptase was responsible for DNA transcription. Viruses produced by transfections in the presence of 3'-azido-3'-deoxythymidine (AZT) contained the viral RNA genome but only DNA of premature length because of the chain terminating effects of AZT. However such viruses were as infectious for CD4(+) cells as wild-type virus. We conclude that retrovirus-derived DNA in HIV-1 particles is not required for infection and does not play a significant role in this process.
引用
收藏
页码:1605 / 1613
页数:9
相关论文
共 50 条
  • [31] MUTATIONS IN THE LEUCINE ZIPPER OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TRANSMEMBRANE GLYCOPROTEIN AFFECT FUSION AND INFECTIVITY
    DUBAY, JW
    ROBERTS, SJ
    BRODY, B
    HUNTER, E
    JOURNAL OF VIROLOGY, 1992, 66 (08) : 4748 - 4756
  • [32] ANTIBODY-MEDIATED INVITRO NEUTRALIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ABOLISHES INFECTIVITY FOR CHIMPANZEES
    EMINI, EA
    NARA, PL
    SCHLEIF, WA
    LEWIS, JA
    DAVIDE, JP
    LEE, DR
    KESSLER, J
    CONLEY, S
    MATSUSHITA, S
    PUTNEY, SD
    GERETY, RJ
    EICHBERG, JW
    JOURNAL OF VIROLOGY, 1990, 64 (08) : 3674 - 3678
  • [33] OPTIMAL INFECTIVITY IN-VITRO OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REQUIRES AN INTACT NEF GENE
    CHOWERS, MY
    SPINA, CA
    KWOH, TJ
    FITCH, NJS
    RICHMAN, DD
    GUATELLI, JC
    JOURNAL OF VIROLOGY, 1994, 68 (05) : 2906 - 2914
  • [34] ROLE OF N-LINKED GLYCANS OF ENVELOPE GLYCOPROTEINS IN INFECTIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    FENOUILLET, E
    GLUCKMAN, JC
    BAHRAOUI, E
    JOURNAL OF VIROLOGY, 1990, 64 (06) : 2841 - 2848
  • [35] DEFINING THE LEVEL OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) PROTEASE ACTIVITY REQUIRED FOR HIV-1 PARTICLE MATURATION AND INFECTIVITY
    ROSE, JR
    BABE, LM
    CRAIK, CS
    JOURNAL OF VIROLOGY, 1995, 69 (05) : 2751 - 2758
  • [36] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIF(-) MUTANT PARTICLES FROM RESTRICTIVE CELLS - ROLE OF VIF IN CORRECT PARTICLE ASSEMBLY AND INFECTIVITY
    BORMAN, AM
    QUILLENT, C
    CHARNEAU, P
    DAUGUET, C
    CLAVEL, F
    JOURNAL OF VIROLOGY, 1995, 69 (04) : 2058 - 2067
  • [37] NEF STIMULATES HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROVIRAL DNA-SYNTHESIS
    AIKEN, C
    TRONO, D
    JOURNAL OF VIROLOGY, 1995, 69 (08) : 5048 - 5056
  • [38] RAPID ENZYMATIC ANALYSIS FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 DNA IN CLINICAL SPECIMENS
    SEVALL, JS
    PRINCE, H
    GARRATTY, G
    OBRIEN, WA
    ZACK, JA
    CLINICAL CHEMISTRY, 1993, 39 (03) : 433 - 439
  • [39] EXPRESSION OF ACTIVE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE BY NONINFECTIOUS CHIMERIC VIRUS-PARTICLES
    KOHL, NE
    DIEHL, RE
    RANDS, E
    DAVIS, LJ
    HANOBIK, MG
    WOLANSKI, B
    DIXON, RAF
    JOURNAL OF VIROLOGY, 1991, 65 (06) : 3007 - 3014
  • [40] MOLECULAR-BIOLOGY OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    HASELTINE, WA
    FASEB JOURNAL, 1991, 5 (10): : 2349 - 2360